Advances in the Treatment of Gynecologic Malignancies
نویسندگان
چکیده
Endometrial cancer is the most common female genital tract cancer in the United States. The majority of cases are confined to the uterus. Treatment of organ-confined uterine cancer usually comprises total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH/BSO). In 1988, clinical staging of endometrial cancer was replaced with surgical staging because of inaccuracies associated with clinical staging. Over the past several decades, we have learned more about the risk factors associated with the recurrence of endometrial cancer. In recent years, few prospective phase III randomized studies have been conducted in patients with endometrial carcinoma to answer questions regarding the best management of these patients.
منابع مشابه
Clinical Impact of 18F-FDG PET/CT on the Management of Gynecologic Cancers: One Center Experience
Objective(s): We aim to investigate the clinical impact of 18F-FDG PET/CT in managing patients with gynecological malignancies and pelvic or extrapelvic lymph nodes that are of equivocal significance on conventional imaging.Methods: We retrospectively evaluated 18F-FDG PET/CT scans of patients with gynecologic tumors who were referred to King Hussein Cancer Center from January 2010 to August 20...
متن کاملGynecologic oncology group trials in uterine corpus malignancies: recent progress.
The Gynecologic Oncology Group (GOG) has conducted multiple trials related to malignancies of the uterine corpus. Recently, several of these trials have been presented and/or published. Areas of focus included the feasibility of laparoscopic staging for endometrial cancer, the adjuvant management of locally advanced endometrial cancer, whole abdominal irradiation in maximally resected advanced ...
متن کاملAdvances in radiation therapy.
the discovery of x-rays by Roentgen and radium by the Curies, the first patient was treated with therapeutic x-rays. During the first few decades of the 20th century, the use of radiation increased significantly. The earliest uses of therapeutic radiation often involved treating gynecologic malignancies. Over the next one hundred years, radiation therapy became one of the integral treatment app...
متن کاملTherapeutic advances in women's cancers.
Cytotoxic therapy and surgery have improved outcomes for patients with gynecologic malignancies over the last twenty years, but women's cancers still account for over ten percent of cancer related deaths annually. Insights into the pathogenesis of cancer have led to the development of drugs that target molecular pathways essential to tumor survival including angiogenesis, DNA repair, and apopto...
متن کاملColorectal and Vulvar Synchronous Cancer: A Case Report
Synchronous cancer is referred to two or more histological distinct malignancies diagnosed during the same hospital admission. Globally more than 1 million people get colorectal cancer yearly resulting in about 0.5 million deaths. Vulvar cancer is the fourth most common gynecologic cancer (following the corpus uterine cancer, cancer of ovary and cervix) and comprises only 4 percent of malignanc...
متن کاملAn update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations.
Gynecologic cancers account for ~12% of all new cancer cases in women and ~15% of all female cancer survivors. Current and continued advances within the field have resulted in long-term outcomes and a high rate of survivors. Therefore determining the most cost-effective clinical surveillance for detection of recurrence is critical. Unfortunately, there has been a paucity of research regarding t...
متن کامل